Scholarlink

Objective <p>The <i>FTO</i> rs9939609 variant is a major common genetic risk factor of adult obesity. We hypothesized that the rs9939609 variant of the fetus alters the plasma glucose (PG) levels during oral glucose tolerance test (OGTT) routinely performed between the 24–28th gestational week.</p> Methods <p>We analysed the data of mother-neonate pairs from our prior gestational diabetes mellitus (GDM) case-control study (Hungarian-Austrian set, <i>n</i> = 858) and the HAPO study European ancestry subset (HAPO-EUR, <i>n</i> = 1374) using pre-pregnancy body mass index (BMI) and maternal age as covariates. The rs8050136 (complete LD with rs9939609) was used in the HAPO-EUR data set.</p> Results <p>Fetal <i>FTO</i> variants were associated (dominant genetic model) with decreased maternal 60’min PG values (ß<sub>Hungarian-Austrian</sub> = −1.39 mmol/L, <i>p</i> = 1.97*10<sup>−4</sup>; ß<sub>HAPO-EUR</sub> = −0.18 mmol/L, <i>p</i> = 4.36*10<sup>−2</sup>; ß<sub>combined</sub> = −0.33 mmol/L, <i>p</i> = 2.11*10<sup>−4</sup>) and with reduced incremental area under glucose curve at OGTT (ß<sub>Hungarian-Austrian</sub> =−1.70 mmol*h/L, <i>p</i> = 3.83*10<sup>−4</sup>; ß<sub>HAPO-EUR</sub> = −0.23 mmol*h/L, <i>p</i> = 2.91*10<sup>−2</sup>; ß<sub>combined</sub> = −0.39 mmol*h/L, <i>p</i> = 1.61*10<sup>−4</sup>).</p> Conclusion <p><i>FTO</i> risk variants carried by the fetus may indirectly influence maternal metabolism and could be associated with a flatter OGTT curve driven by the reduced 1 h postload PG levels in pregnancy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association of fetal FTO gene variants with maternal postload glucose levels in pregnancy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月28日

查看全文
  • Gábor Firneisz,
  • Ákos Nádasdi,
  • Botond A. Nemes,
  • László Németh,
  • Klara Rosta,
  • Jürgen Harreiter,
  • Alexandra Kautzky-Willer,
  • Anikó Somogyi,
  • Zoltán Benyó

摘要

Objective

The FTO rs9939609 variant is a major common genetic risk factor of adult obesity. We hypothesized that the rs9939609 variant of the fetus alters the plasma glucose (PG) levels during oral glucose tolerance test (OGTT) routinely performed between the 24–28th gestational week.

Methods

We analysed the data of mother-neonate pairs from our prior gestational diabetes mellitus (GDM) case-control study (Hungarian-Austrian set, n = 858) and the HAPO study European ancestry subset (HAPO-EUR, n = 1374) using pre-pregnancy body mass index (BMI) and maternal age as covariates. The rs8050136 (complete LD with rs9939609) was used in the HAPO-EUR data set.

Results

Fetal FTO variants were associated (dominant genetic model) with decreased maternal 60’min PG values (ßHungarian-Austrian = −1.39 mmol/L, p = 1.97*10−4; ßHAPO-EUR = −0.18 mmol/L, p = 4.36*10−2; ßcombined = −0.33 mmol/L, p = 2.11*10−4) and with reduced incremental area under glucose curve at OGTT (ßHungarian-Austrian =−1.70 mmol*h/L, p = 3.83*10−4; ßHAPO-EUR = −0.23 mmol*h/L, p = 2.91*10−2; ßcombined = −0.39 mmol*h/L, p = 1.61*10−4).

Conclusion

FTO risk variants carried by the fetus may indirectly influence maternal metabolism and could be associated with a flatter OGTT curve driven by the reduced 1 h postload PG levels in pregnancy.